Cargando…

m6A-related metabolism molecular classification with distinct prognosis and immunotherapy response in soft tissue sarcoma

N6-methyladenosine (m6A) methylation, one of the most crucial RNA modifications, has been proven to play a key role that affect prognosis of soft tissue sarcoma (STS). However, m6A methylation potential role in STS metabolic processes remains unknown. We comprehensively estimated the m6A metabolic m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Zhen-Dong, Fu, Yong-Cheng, Liu, Shu-Yan, Mao, Ya-Juan, Zhang, Yan, Hu, Chao, Wei, Ren-Xiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374037/ https://www.ncbi.nlm.nih.gov/pubmed/35967408 http://dx.doi.org/10.3389/fimmu.2022.895465

Ejemplares similares

m6A Modification Patterns With Distinct Immunity, Metabolism, and Stemness Characteristics in Soft Tissue Sarcoma
por: Huang, Zhen-Dong, et al.
Publicado: (2021)

Stemness Subtypes and Scoring System Predict Prognosis and Efficacy of Immunotherapy in Soft Tissue Sarcoma
por: Gu, Hui-Yun, et al.
Publicado: (2022)

Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review
por: Roulleaux Dugage, Matthieu, et al.
Publicado: (2021)

Comprehensive Profiling Reveals Prognostic and Immunogenic Characteristics of Necroptosis in Soft Tissue Sarcomas
por: Qi, Lin, et al.
Publicado: (2022)

Immunotherapy for Bone and Soft Tissue Sarcomas
por: Uehara, Takenori, et al.
Publicado: (2015)

Cancer Testis Antigens and Immunotherapy: Expression of PRAME Is Associated with Prognosis in Soft Tissue Sarcoma
por: Albertsmeier, Markus, et al.
Publicado: (2020)

New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas
por: Seong, Gyuhee, et al.
Publicado: (2023)

DNA methylation patterns–based subtype distinction and identification of soft tissue sarcoma prognosis
por: Li, Kai, et al.
Publicado: (2021)

Cross-Talk of Multiple Types of RNA Modification Regulators Uncovers the Tumor Microenvironment and Immune Infiltrates in Soft Tissue Sarcoma
por: Qi, Lin, et al.
Publicado: (2022)

Meta-Analysis of Hematological Biomarkers as Reliable Indicators of Soft Tissue Sarcoma Prognosis
por: Li, Long-Qing, et al.
Publicado: (2020)

VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?
por: Albertsmeier, Markus, et al.
Publicado: (2022)

Classification of colon adenocarcinoma based on immunological characterizations: Implications for prognosis and immunotherapy
por: Xu, Midie, et al.
Publicado: (2022)

Correlative Study on the Relationship between the Expression of m6a-Related Genes and the Prognosis and Immunotherapy of Soft Tissue Sarcoma
por: Qiu, Yue, et al.
Publicado: (2022)

Deciphering the role of NETosis-related signatures in the prognosis and immunotherapy of soft-tissue sarcoma using machine learning
por: Qi, Lin, et al.
Publicado: (2023)

Addressing the Adult Soft Tissue Sarcoma Microenvironment with Intratumoral Immunotherapy
por: Raj, Shailaja, et al.
Publicado: (2018)

Hyperprogression of Liver Metastasis With Neoadjuvant Immunotherapy for Soft Tissue Sarcoma
por: Chan, Abigail S, et al.
Publicado: (2020)

Current Status and Future Directions of Immunotherapies in Soft Tissue Sarcomas
por: Kerrison, William G. J., et al.
Publicado: (2022)

Immunotherapy in soft tissue and bone sarcoma: unraveling the barriers to effectiveness
por: Panagi, Myrofora, et al.
Publicado: (2022)

Nanomaterial Technology and Soft Tissue Sarcomas
por: Zhou, Changkai, et al.
Publicado: (2022)

Integrated Analysis of Nine Prognostic RNA-Binding Proteins in Soft Tissue Sarcoma
por: Lin, Lu-Lu, et al.
Publicado: (2021)

Case Report: Immunotherapy for low-grade myofibroblastic sarcoma of the pharynx
por: Sun, Bao, et al.
Publicado: (2023)

The role of cuproptosis-related gene in the classification and prognosis of melanoma
por: Liu, Jin-Ya, et al.
Publicado: (2022)

Integrative profiling analysis reveals prognostic significance, molecular characteristics, and tumor immunity of angiogenesis-related genes in soft tissue sarcoma
por: Liu, Binfeng, et al.
Publicado: (2023)

A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas
por: Monga, Varun, et al.
Publicado: (2020)

Tumor and Peripheral Immune Status in Soft Tissue Sarcoma: Implications for Immunotherapy
por: Sousa, Luana Madalena, et al.
Publicado: (2021)

The Role of Natural Killer Cells in Soft Tissue Sarcoma: Prospects for Immunotherapy
por: Fortes-Andrade, Tânia, et al.
Publicado: (2021)

Intratumoral STING activation causes durable immunogenic tumor eradication in the KP soft tissue sarcoma model
por: Marritt, Kayla L., et al.
Publicado: (2023)

Integration analysis based on fatty acid metabolism robustly predicts prognosis, dissecting immunity microenvironment and aiding immunotherapy for soft tissue sarcoma
por: Liu, Binfeng, et al.
Publicado: (2023)

Identification and Validation of a Novel Pyroptosis-Related Gene Signature for Prognosis Prediction in Soft Tissue Sarcoma
por: Qi, Lin, et al.
Publicado: (2021)

Machine learning-based glycolysis-associated molecular classification reveals differences in prognosis, TME, and immunotherapy for colorectal cancer patients
por: Wang, Zhenling, et al.
Publicado: (2023)

Identification of anoikis-related molecular patterns to define tumor microenvironment and predict immunotherapy response and prognosis in soft-tissue sarcoma
por: Qi, Lin, et al.
Publicado: (2023)

Impact of Limb Salvage on Prognosis of Patients Diagnosed With Extremity Bone and Soft Tissue Sarcomas
por: Yu, Kaixu, et al.
Publicado: (2022)

Soft-tissue Sarcomas
por: Vodanovich, Domagoj Ante, et al.
Publicado: (2018)

Treatment and prognosis of iliac fossa soft tissue sarcoma: A single‐center study
por: Sun, Wei, et al.
Publicado: (2020)

Immunotherapy for Soft Tissue Sarcomas: Anti-PD1/PDL1 and Beyond
por: Fazel, Mina, et al.
Publicado: (2023)

Impact of Unplanned Excision on Prognosis of Patients with Extremity Soft Tissue Sarcoma
por: Umer, Hafiz Muhammad, et al.
Publicado: (2013)

Associations of clock genes polymorphisms with soft tissue sarcoma susceptibility and prognosis
por: Benna, Clara, et al.
Publicado: (2018)

Molecular Subtypes Based on Cell Differentiation Trajectories in Head and Neck Squamous Cell Carcinoma: Differential Prognosis and Immunotherapeutic Responses
por: Huang, Zhen-Dong, et al.
Publicado: (2021)

Soft tissue sarcoma subtypes exhibit distinct patterns of acquired uniparental disomy
por: Tuna, Musaffe, et al.
Publicado: (2012)

Immunological Classification of Tumor Types and Advances in Precision Combination Immunotherapy
por: Ren, Xiufang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_im49ndlbf95l1u89vj0s3tc0pl